Skip to content

Family-Based Prevention Program for Childhood Anxiety

Family-Based Prevention for Childhood Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00078728
Enrollment
40
Registered
2004-03-08
Start date
2003-09-30
Completion date
2007-07-31
Last updated
2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Keywords

Anxiety

Brief summary

This study will evaluate the effectiveness of a short-term family-based program for preventing anxiety disorders in at-risk children.

Detailed description

Anxiety disorders are serious conditions that can negatively impact a person's overall functioning. This study will enroll mothers with anxiety disorders and their children to determine whether a brief family-based intervention will reduce childhood anxiety better than standard care. Participants will be randomly assigned to either the family-based prevention program or to evaluation only for 8 weeks. Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety. Self- and parent-reports, diagnostic interviews, a computerized memory task, and a videotaped parent-child interaction task will be used to assess participants. Assessments will be conducted at study start and one week after intervention completion (Week 9). Follow-up visits will be conducted at 6 and 12 months after intervention completion.

Interventions

BEHAVIORALFamily-Based Anxiety Prevention Program

Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. The intervention will begin immediately after randomization to the study.

BEHAVIORALEvaluation only

Participants will undergo evaluations without active treatment for 8 weeks.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mothers with a current, primary anxiety disorder * 7-12 year old children without an anxiety disorder

Exclusion criteria

* Mothers that do not have a current, primary anxiety disorder * 7-12 year old children with an anxiety disorder * 7-12 year old children that are currently receiving treatment for anxiety that could interfere with the study

Design outcomes

Primary

MeasureTime frameDescription
Number of Children With Child Anxiety Diagnosis12 monthMeasured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions.
Child Anxiety Diagnoses12 monthsThe cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder.

Countries

United States

Participant flow

Participants by arm

ArmCount
1 Family-based Prevention Program
Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks.
20
2 Evaluation Only
Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks.
20
Total40

Baseline characteristics

Characteristic2 Evaluation Only1 Family-based Prevention ProgramTotal
Age, Categorical
<=18 years
20 Participants20 Participants40 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous8.68 years
STANDARD_DEVIATION 1.81
9.20 years
STANDARD_DEVIATION 1.91
8.94 years
STANDARD_DEVIATION 1.85
Region of Enrollment
United States
20 participants20 participants40 participants
Sex: Female, Male
Female
8 Participants10 Participants18 Participants
Sex: Female, Male
Male
12 Participants10 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Child Anxiety Diagnoses

The cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder.

Time frame: 12 months

ArmMeasureValue (NUMBER)
1 Family-based Prevention ProgramChild Anxiety Diagnoses0 participants
2 Evaluation OnlyChild Anxiety Diagnoses6 participants
Primary

Number of Children With Child Anxiety Diagnosis

Measured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions.

Time frame: 12 month

ArmMeasureValue (NUMBER)
1 Family-based Prevention ProgramNumber of Children With Child Anxiety Diagnosis20 participants
2 Evaluation OnlyNumber of Children With Child Anxiety Diagnosis20 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026